Online Size-exclusion and Ion-exchange Chromatography on a SAXS Beamline
January 5th, 2017
The determination of the solution structure of a protein by small angle X-ray scattering (SAXS) requires monodisperse samples. Here, we present two possibilities to ensure minimal delays between sample preparation and data acquisition: online size-exclusion chromatography (SEC) and online ion-exchange chromatography (IEC).
Overview
This study explores the implementation of online size-exclusion chromatography (SEC) and ion-exchange chromatography (IEC) in small angle X-ray scattering (SAXS) to enhance data quality. By minimizing delays between sample preparation and data acquisition, the methods aim to improve structural biology analyses.
Key Study Components
Area of Science
- Structural Biology
- Biophysical Techniques
- Protein Analysis
Background
- SAXS requires monodisperse samples for accurate structural determination.
- Delays in sample processing can lead to denaturation and affect data quality.
- Online SEC and IEC can streamline the preparation process.
- These methods can provide insights into protein structure and dynamics.
Purpose of Study
- To implement online SEC and IEC in SAXS experiments.
- To reduce the time between sample preparation and measurement.
- To enhance the quality of SAXS data for structural analysis.
Methods Used
- Preparation of concentrated protein samples using established methods.
- Integration of SEC and IEC with SAXS beamline setups.
- Monitoring of scattering intensity to assess radiation damage.
- Post-processing of SAXS data to analyze scattering curves.
Main Results
- Successful implementation of SEC and IEC improved data quality.
- Minimized sample denaturation during the SAXS measurement process.
- Enhanced ability to analyze protein structure and dynamics.
- Provided a framework for future SAXS experiments.
Conclusions
- Online SEC and IEC are effective for SAXS sample preparation.
- These methods can significantly improve the reliability of structural data.
- Future studies can build on this framework for advanced structural biology research.
Frequently Asked Questions
Executive Industry Relevance
Integrating online size-exclusion and ion-exchange chromatography with BioSAXS enables rapid, high-fidelity structural characterization of biotherapeutic candidates by minimizing sample degradation and aggregation. This workflow enhances predictive confidence in early-stage discovery by ensuring monodisperse, native-state samples for solution-phase structural analysis. The approach supports critical inflection points in biologics R&D, including target validation and mechanistic de-risking for complex protein systems.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables direct assessment of protein oligomeric state and conformational integrity in solution.
- Supports mechanistic de-risking by clarifying macromolecular assembly and folding status.
- Facilitates rapid triage of candidate molecules based on solution structure and aggregation propensity.
Screening & Assay Development
- Prepares highly purified, monodisperse samples for downstream biophysical and functional assays.
- Standardizes sample quality, reducing variability in quantitative structural measurements.
- Enables reproducible, high-throughput screening of protein constructs for developability.
Translational & Preclinical Research
- Aligns solution-phase structural data with preclinical developability assessments.
- Provides continuity from discovery-stage characterization to preclinical candidate selection.
- De-risks advancement decisions by confirming molecular integrity under physiologically relevant conditions.
Pipeline & Workflow Integration
This integrated chromatography-SAXS workflow bridges early discovery and preclinical research by delivering rapid, quantitative structural insights on candidate proteins.
- Discovery Biology: Supports hypothesis testing on protein assembly, folding, and solution behavior.
- Screening: Delivers reproducible, quantitative readouts of particle size, shape, and aggregation state.
- Analytics: Provides robust measurements of radius of gyration, molecular weight, and ab initio shape models.
- Translational Research: Ensures structural data continuity for risk-adjusted candidate progression.
- Enterprise Reuse: Establishes a scalable, standardized platform for structural assessment across diverse protein targets.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in target validation and mechanistic understanding.
- Operational Value: Streamlines sample preparation and data acquisition, reducing turnaround time and manual intervention.
- Strategic Value: Improves go/no-go decision quality by providing high-resolution, solution-phase structural data.
- Portfolio Impact: Enables risk-adjusted prioritization of biologics candidates based on developability and structural integrity.
Implementation Considerations
- Requires expertise in chromatography, SAXS instrumentation, and data analysis.
- Demands access to HPLC systems integrated with SAXS beamlines and robust data processing infrastructure.
- Necessitates rigorous cross-team standardization of sample preparation and buffer conditions.
- May require adaptation for different protein classes or buffer systems to optimize separation and data quality.
- Protein concentration determination can be challenging, impacting absolute mass measurements.
Biopharma FAQs
Chapters in this video
0:05
Title
0:51
Size-exchange Chromatography (SEC)-Small Angle X-ray Scattering (SAXS) Data Collection
3:46
Ion-exchange Chromatography (IEC)-SAXS Data Collection
7:37
SAXS Data Reduction and Analysis
8:59
Results: SEC- and IEC-SAXS Analysis of D5323-785
9:55
Conclusion
